Date Field | Doc. No. | Description (Pages) |
---|
Dec 21, 2021 | 6 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [5], Doc No. [4], Doc No. [3], ERROR: Documents filed in a member case. CORRECTION: Future documents should be filed in the lead appeal only 22-1194. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [820085] [JCW] [Entered: 12/21/2021 08:46 AM] (0) |
Dec 20, 2021 | 3 | Entry of appearance for George F. Pappas; Einar Stole; Brianne Bharkhda; Kurt Calia as counsel for Appellees Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. and H. Lundbeck A/S. Service: 12/20/2021 by email. [820046] [22-1208] [George Pappas] [Entered: 12/20/2021 06:09 PM] (2) |
Dec 20, 2021 | 4 | Certificate of Interest for Appellees H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/20/2021 by email. [820048] [22-1208] [George Pappas] [Entered: 12/20/2021 06:11 PM] (4) |
Dec 20, 2021 | 5 | Docketing Statement for the Appellees H. Lundbeck A/S, Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/20/2021 by email. [820050] [22-1208] [George Pappas] [Entered: 12/20/2021 06:12 PM] (2) |
Dec 1, 2021 | 1 | Appeal docketed. Received: 11/29/2021. [815562]Entry of Appearance is due on 12/15/2021. Certificate of Interest is due on 12/15/2021. Docketing Statement is due on 12/15/2021. Appellants' brief is due on 01/31/2022. [JCW] [Entered: 12/01/2021 11:19 AM] (183) |
Dec 1, 2021 | 2 | Note to File: The following cases are consolidated: 22-1194 Lead with 22-1208 Cross-Appeal. The parties must file all documents in the lead appeal only. [815566] [22-1194, 22-1208] [JCW] [Entered: 12/01/2021 11:23 AM] (0) |